Making a noteworthy insider sell on October 9, ITEM SECOND IRR TRUST FBO JACOB J WESTPHAL ua of JEFFREY R WESTPHAL dated October , 10% Owner at Vertex VERX, is reported in the latest SEC filing.

Vertex Pharmaceuticals (VRTX) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of ...

According to recent filings, an insider associated with Vertex Inc. ( VERX, Financial ), a leading provider of tax technology ...

What Happened: Westphal's decision to sell 1,225,000 shares of Vertex was revealed in a Form 4 filing with the U.S. Securities and Exchange Commission on Monday. The total value of the sale is $48,289 ...

With an FDA decision looming over its first foray into the acute pain space, Vertex Pharmaceuticals has commissioned a pair ...

An energy company has reverted from producing renewable fuels back to conventional production just weeks after filing for ...

Corporate tax compliance software Vertex stock scores a breakout amid an array of acquisitions, as earnings growth begins to ...

Adirondack Trust Co. lowered its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by ...

Vertex’s core cystic fibrosis portfolio remains its top/bottom-line driver, with elongated patent expiry for TRIKAFTA/KAFTRIO ...

Vertex Energy Inc (VTNR) stock saw a decline, ending the day at $0.11 which represents a decrease of $-0.01 or -8.33% from the prior close of $0.12. The stock opened at $0.11 and touched a low of $0.1 ...

Morgan Stanley analyst Terence Flynn maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research Report) today and set a price ...